Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone‐refractory prostate carcinoma
Heidenreich, Axel, Sommer, Frank, Ohlmann, Carsten H., Schrader, Andres J., Olbert, Peter, Goecke, Joachim, Engelmann, Udo H.
Published in Cancer (01.09.2004)
Published in Cancer (01.09.2004)
Get full text
Journal Article